Biocon Drug Itolizumab Gets Government Approval As COVID-19 Medication In India
Biocon drug Itolizumab has received clearance from the Drugs Controller General of India for treating moderate to severe COVID-19 patients.
- Sponsored -
- Sponsored -
- Sponsored -